csa-treated animals developed a notable hypertension , along with a striking rise in pra , which was not coupled with significant changes in the plasma concentrations of aldosterone and corticosterone ( hyperreninemic hypoaldosteronism ) .
C0010592
csa
C0020538
hypertension